ADVAIR DISKUS
fluticasone propionate and salmeterol
- Strength
- 500 ug/1, 50 ug/1
- Form
- Powder
- Class
- Corticosteroid; beta2-Adrenergic Agonist
A-S Medication Solutions
Not stocked by us — reference only
salmeterol xinafoate
Listed by GlaxoSmithKline LLC
| Dosage form | Powder, Metered |
|---|---|
| Route | Oral, Respiratory (inhalation) |
| Drug class | beta2-Adrenergic Agonist |
| Approval route | NDA — original brand approval |
| NDC code | 0173-0521 |
| FDA application | NDA020692 |
| RxNorm concept | 866048 |
| Package sizes listed | 1 |
| Marketed since | November 1997 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
fluticasone propionate and salmeterol
A-S Medication Solutions
Not stocked by us — reference only
fluticasone propionate and salmeterol
A-S Medication Solutions
Not stocked by us — reference only
fluticasone propionate and salmeterol
A-S Medication Solutions
Not stocked by us — reference only
fluticasone propionate and salmeterol
GlaxoSmithKline LLC
Not stocked by us — reference only
fluticasone propionate and salmeterol
A-S Medication Solutions
Not stocked by us — reference only
fluticasone propionate and salmeterol
A-S Medication Solutions
Not stocked by us — reference only
fluticasone propionate and salmeterol
GlaxoSmithKline LLC
Not stocked by us — reference only
fluticasone propionate and salmeterol
GlaxoSmithKline LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.